A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease by Boursnell, M. E. G., Entwisle, C., Blakeley, D., Roberts, C., Duncan, I. A., Chisholm, S. E., Martin, G. M., Jennings, R., Ní Challanaín, D., Sobek, I., Inglis, S. C., McLean, C. S.

Request full text

Protective Vaccination Against Primary And Recurrent Disease Caused By Herpes Simplex Virus (HSV) Type 2 Using A Genetically Disabled HSV-1 by Mclean, C. S., Erturk, M., Jennings, R., Ni Challanain, D., Minson, A. C., Duncan, I., Boursnell, M. E. G., Inglis, S. C.

Get full text

Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine by McLean, C.S., NíChallanáin, D., Duncan, I., Boursnell, M.E.G., Jennings, R., Inglis, S.C.

Get full text

Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1 by McLean, C S, Erturk, M, Jennings, R, Ni Challanain, D, Minson, A C, Duncan, I, Boursnell, MEG, Inglis, S C

Get full text

Migration and community in Bronze Age Orkney: innovation and continuity at the Links of Noltland by Moore, Hazel, Wilson, Graeme, Ni Challanain, Mairead, McCormick, Maeve, Marshall, Peter D., Dulias, Katharina, Foody, M. George B., Justeau, Pierre, Pala, Maria, Richards, Martin B., Edwards, Ceiridwen J.

Get full text